EUVIMEDEUVIMED entdecken
Open Access

TNK1 is a targetable JAK-independent driver of STAT signaling and inflammation

Tania P López-Palacios, Deshan Madhusanka, Samuel M Scott, Alec J Vaughan, Christina M Egbert, Tsz-Yin Chan, Yaphet Bustos, Spencer W Ashworth, Jacob M Truman, Angela Per Moreno, Tsz-Ming Tsang, Dasun N Jayatunge und 19 weitere

Genes & Development · 2026

DOI: 10.1101/gad.353368.125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Development, 2026. Verfasst von Tania P López-Palacios und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Sciences, University of Utah, Salt Lake City, Utah 84112, USA. Hauptthemen laut MEDLINE: Signal Transduction, Inflammation, Protein-Tyrosine Kinases, STAT1 Transcription Factor. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Fritz B. Burns Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deregulated inflammatory signaling via STAT family transcription factors, particularly STAT1, underlies a variety of immune-related diseases, including inflammatory bowel disease. Whereas activation of STATs by JAKs via canonical receptor-driven JAK–STAT signaling is well understood, little is known about JAK-independent mechanisms of STAT activation. Here, we identify the understudied nonreceptor tyrosine kinase TNK1 as a therapeutically targetable, JAK-independent activator of STAT signaling. Using a multiomics approach, we mapped a network of TNK1 substrates associated with protein condensates and proinflammatory signaling, including STAT1. We found that TNK1, but not its sister kinase ACK1, directly phosphorylates STATs at well described STAT-activating JAK sites. In cells, TNK1-mediated STAT1 phosphorylation and activation occurs independently of JAKs. Imaging and interactomics data suggest that TNK1 interacts with STAT1 in cytosolic condensates, which likely compartmentalize TNK1-substrate interactions. We show that an intrinsically disordered proline-rich region in TNK1, which includes a 14-3-3 docking phosphorylation site, is required for the formation of kinase-active TNK1 condensates and STAT1 phosphorylation. Mutations within the proline-rich region that eliminate 14-3-3 binding increase formation of TNK1 condensates, suggesting a model in which 14-3-3 acts as a clamp that constrains the flexible PRR to inhibit condensate formation and STAT1 activation. Finally, we show that TNK1 is a targetable driver of STAT1-mediated inflammation in the gut as inhibition of TNK1 reduces active STAT1 in the colon and ameliorates colitis symptoms in mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionInflammationProtein-Tyrosine KinasesSTAT1 Transcription FactorAnimalsPhosphorylationHumansMiceJanus Kinases14-3-3 ProteinsProtein BindingFetal Proteins

Stichwörter der Autor:innen

14-3-3STAT1condensatekinase

Substanzen

Protein-Tyrosine KinasesSTAT1 Transcription FactorJanus KinasesTNK1 protein, human14-3-3 ProteinsFetal Proteins

Autor:innen und Institutionen

  • Department of Oncological Sciences, University of Utah, Salt Lake City, Utah 84112, USA.
  • Fritz B. Burns Cancer Research Laboratory, Salt Lake City, Utah 84112, USA.
  • Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602, USA.
  • Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA.
  • Proteomics and Metabolomics Shared Resources, Duke University School of Medicine, Durham, North Carolina 27710, USA.
  • Cancer Bioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA.

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Fritz B. Burns Foundation
  • National Institutes of Health
  • National Institute of General Medical Sciences
  • Simmons Center for Cancer Research

Zitieren

APA

López-Palacios, T. P., Madhusanka, D., Scott, S. M., Vaughan, A. J., Egbert, C. M., Chan, T. Y., Bustos, Y., Ashworth, S. W., Truman, J. M., Per Moreno, A., Tsang, T. M., Jayatunge, D. N., Yang, J., Nelson, P., Al-Sudani, F., Tarara, M., Kohler, E., Pereira Mendiola, N. E., Soderblom, E. J., …, & Andersen, J. L. (2026). TNK1 is a targetable JAK-independent driver of STAT signaling and inflammation. Genes & Development. https://doi.org/10.1101/gad.353368.125

Vancouver

López-Palacios TP, Madhusanka D, Scott SM, Vaughan AJ, Egbert CM, Chan TY, et al. TNK1 is a targetable JAK-independent driver of STAT signaling and inflammation. Genes & Development. 2026. doi:10.1101/gad.353368.125

BibTeX
@article{LpezPalacios2026,
  author = {López-Palacios, Tania P and Madhusanka, Deshan and Scott, Samuel M and Vaughan, Alec J and Egbert, Christina M and Chan, Tsz-Yin and Bustos, Yaphet and Ashworth, Spencer W and Truman, Jacob M and Per Moreno, Angela and Tsang, Tsz-Ming and Jayatunge, Dasun N and Yang, Jingshu and Nelson, Paige and Al-Sudani, Fatima and Tarara, Madelyn and Kohler, Emmalee and Pereira Mendiola, Nelson E and Soderblom, Erik J and Stubben, Chris J and Stewart, Paul A and Kolasangiani, Reza and Dobish, Kasidy K and Knobel, Beate and Buckley, Shannon M and Bidone, Tamara C and Smoot, Rory L and Uchida, Amiko M and Morawe, Mareen and Armacki, Milena and Andersen, Joshua L},
  title = {TNK1 is a targetable JAK-independent driver of STAT signaling and inflammation},
  journal = {Genes & Development},
  year = {2026},
  doi = {10.1101/gad.353368.125}
}
Kostenlos starten →